Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Am J Kidney Dis. 2017 Aug 24;70(6):834–843. doi: 10.1053/j.ajkd.2017.07.004

Table 4.

Biomarker profiling for the 5 C4Nef-positive patients

Patient No. C3, g/L (ref 0.9–1.8) C3c, mg/L (ref < 2) C4, g/L (ref 0.15–0.47) C4a, mg/L (ref <0.72) C2, mg/L (ref 34–50) fB, mg/L (ref 155–250) Ba, mg/L (ref <1.2) Bb, mg/L (ref <1.2) C5, mg/dL (ref 55–125) P, mg/L (ref 11–33) sC5b-9, mg/L (ref <0.3)
1 <0.1 2.3 0.18 0.17 35.3 200 0.3 0.9 39.5 9.3 1.6
2 0.25 2.0 0.45 0.78 27.1 171 2.0 2.0 40.2 8.4 2.8
3 0.4 2.7 0.24 0.71 38.2 163 1.2 2.0 35.5 10.3 1.9
4 0.65 2.1 0.34 1.22 35.7 158 1.4 1.3 61.7 21.3 0.8
5 0.11 3.4 0.19 0.25 35.9 225 0.7 1.1 24.9 10.5 1.9

Note: Date of testing as for Table 3; normal reference (ref) values are listed under each biomarker C4NeF, C4 nephritic factor